Dashboard
Manage Tickers

ABBV


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

abbvie-shares-rise-to-intraday-high-after-key-trading-signal
AbbVie Shares Rise To Intraday High After ...
11/12/2025 20:06:26

A key trading signal flashed for AbbVie shares at a price of $228.47, after which ABBV rose as much as 2.4% to an intraday high...

Core News & Articles
'AbbVie cuts ties with Google-backed longe...
11/12/2025 16:03:56

https://www.statnews.com/2025/11/12/abbvie-calico-layoffs/?utm_campaign=twitter_organic&utm_source=twitter&utm_medium=s...

abbvies-allergan-to-present-at-american-society-of-dermatologic-surgery-asds-annual-meeting-nov-13-16
AbbVie's Allergan To Present At American S...
11/12/2025 13:36:48

ubs-maintains-neutral-on-abbvie-raises-price-target-to-220
UBS Maintains Neutral on AbbVie, Raises Pr...
11/07/2025 16:15:42

UBS analyst Ashwani Verma maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $195 to $220.

100-invested-in-abbvie-5-years-ago-would-be-worth-this-much-today
$100 Invested In AbbVie 5 Years Ago Would ...
11/05/2025 20:45:42

piper-sandler-reiterates-overweight-on-abbvie-raises-price-target-to-289
Piper Sandler Reiterates Overweight on Abb...
11/05/2025 15:42:26

Piper Sandler analyst David Amsellem reiterates AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $284 t...

Core News & Articles
Calico Life Sciences Announces U.S. FDA Or...
11/05/2025 15:08:51

Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphab...

citigroup-maintains-neutral-on-abbvie-lowers-price-target-to-235
Citigroup Maintains Neutral on AbbVie, Low...
11/03/2025 20:08:03

Citigroup analyst Geoff Meacham maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $240 to $235.

what-the-options-market-tells-us-about-abbvie
What the Options Market Tells Us About AbbVie
11/03/2025 17:02:44

jp-morgan-maintains-overweight-on-abbvie-raises-price-target-to-260
JP Morgan Maintains Overweight on AbbVie, ...
11/03/2025 14:40:01

JP Morgan analyst Chris Schott maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $250 to $260.

looking-into-abbvie-incs-recent-short-interest
Looking Into AbbVie Inc's Recent Short Int...
10/31/2025 20:00:42

nasdaq-100-rebounds-amazon-jumps-10-on-strong-earnings-whats-moving-markets-friday
Nasdaq 100 Rebounds, Amazon Jumps 10% On S...
10/31/2025 17:26:36

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...

abbvie-raises-2025-outlook-helped-by-strong-immunology-growth-boost-dividend
AbbVie Raises 2025 Outlook Helped By Stron...
10/31/2025 15:47:20

AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfol...

abbvie-executive-says-administrations-focus-on-achieving-greater-reductions-in-2027-medicare-drug-price-negotiation-round-was-clear-but-outcomes-will-not-impact-long-term-outlook
AbbVie Executive Says Administration's Foc...
10/31/2025 13:58:14

-Reuters

abbvie-raises-fy2025-adj-eps-guidance-from-1038-1058-to-1061-1065-vs-1053-est
AbbVie Raises FY2025 Adj EPS Guidance from...
10/31/2025 11:57:41

AbbVie (NYSE:ABBV) raises FY2025 Adj EPS guidance from $10.38-$10.58 to $10.61-$10.65 vs $10.53 analyst estimate..

abbvie-q3-adj-eps-186-beats-179-estimate-sales-15776b-beat-15590b-estimate
AbbVie Q3 Adj. EPS $1.86 Beats $1.79 Estim...
10/31/2025 11:56:32

AbbVie (NYSE:ABBV) reported quarterly earnings of $1.86 per share which beat the analyst consensus estimate of $1.79 by 4.09 pe...

abbvie-increases-quarterly-dividend-from-164-per-share-to-173-per-share-payable-on-february-17-2026-to-shareholders-of-record-january-16
AbbVie Increases Quarterly Dividend From $...
10/31/2025 11:55:18

earnings-scheduled-for-october-31-2025
Earnings Scheduled For October 31, 2025
10/31/2025 11:11:48

eli-lilly-extends-lead-in-150b-obesity-drug-race-as-novo-pfizer-clash--heres-how-etfs-stand-to-gain
Eli Lilly Extends Lead In $150B Obesity Dr...
10/30/2025 20:04:44

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the...

abbvies-earnings-outlook
AbbVie's Earnings Outlook
10/30/2025 14:02:37

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION